Mersana Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Mersana Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Mersana Therapeutics Inc
Rating: 1.08491675
Author: Trendlyne DVM scores

about

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

7.48 -0.18 (-2.35%)

89.43% Fall from 52W High

12,901

XNAS Volume

XNAS 29 Aug, 2025 11:36 AM (EDT)

Not Eligible

Expensive Valuation

14.7 / 100

Technically Bearish

28.7 / 100

1Yr Price target upside is 278%

7 analysts

Mersana Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mersana Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

89.43% Fall from 52W High

SWOT Analysis

Mersana Therapeutics Inc Live Price Chart